Proteinase-Activated Receptor-2 Agonists as Adjuvants for Mucosal Vaccination
Proteinase-Activated Receptor-2 Agonists as Adjuvants for Mucosal Vaccination
批准号:
435452
负责人:
Vliagoftis Harissios
金额:
$72.73万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
未结题
起止时间:
2020-10-01 至 2025-10-01
中文摘要
流感是由流感病毒感染引起的肺部疾病。流感感染在冬季非常常见,可能导致脆弱人群死亡,如非常年轻,非常年老和患有慢性病的人。一种方法来减少
英文摘要
The flu is a lung disease caused by infection with the influenza virus. Flu infections are very common during the winter months and can cause death in vulnerable people such as the very young, the very old, and those with chronic diseases. One way to decr
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acute airway inflammation induced by vaping
-
批准号:425157
-
项目类别:Operating Grants
-
资助金额:$7.28万
-
财政年份:2020
-
负责人:Vliagoftis Harissios
-
依托单位:
Proteinase-Activated Receptors as a therapeutic target in allergic inflammation
-
批准号:328217
-
项目类别:Salary Programs
-
资助金额:$6.19万
-
财政年份:2015
-
负责人:Vliagoftis Harissios
-
依托单位:
Proteinase-Activated Receptors as a therapeutic target in allergic inflammation
-
批准号:330169
-
项目类别:Operating Grants
-
资助金额:$9.11万
-
财政年份:2015
-
负责人:Vliagoftis Harissios
-
依托单位:
Proteinase-Activated Receptor-2 (PAR-2) as a therapeutic target for allergic airway inflammation
-
批准号:292162
-
项目类别:Operating Grants
-
资助金额:$49.8万
-
财政年份:2013
-
负责人:Vliagoftis Harissios
-
依托单位:
海外基金